273 related articles for article (PubMed ID: 36077772)
1. The Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Neither Hot nor Cold.
Rubin SJS; Sojwal RS; Gubatan J; Rogalla S
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077772
[TBL] [Abstract][Full Text] [Related]
2. Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma.
Gautam SK; Batra SK; Jain M
Mol Cancer; 2023 Jul; 22(1):118. PubMed ID: 37488598
[TBL] [Abstract][Full Text] [Related]
3. Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics.
Ijichi H
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230803
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic Tumor Microenvironment.
Wang K; He H
Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
[TBL] [Abstract][Full Text] [Related]
5. CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model.
Wang R; Chen J; Wang W; Zhao Z; Wang H; Liu S; Li F; Wan Y; Yin J; Wang R; Li Y; Zhang C; Zhang H; Cao Y
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35086948
[TBL] [Abstract][Full Text] [Related]
6. Integrated transcriptional analysis reveals macrophage heterogeneity and macrophage-tumor cell interactions in the progression of pancreatic ductal adenocarcinoma.
Yang K; Yang T; Yu J; Li F; Zhao X
BMC Cancer; 2023 Mar; 23(1):199. PubMed ID: 36864399
[TBL] [Abstract][Full Text] [Related]
7. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
Front Immunol; 2021; 12():643529. PubMed ID: 33679807
[No Abstract] [Full Text] [Related]
8. Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal adenocarcinoma.
Liu X; Liu J; Xu J; Zhang B; Wei M; Li J; Xu H; Yu X; Wang W; Shi S
Transl Oncol; 2023 Jan; 27():101561. PubMed ID: 36257208
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target.
Hartupee C; Nagalo BM; Chabu CY; Tesfay MZ; Coleman-Barnett J; West JT; Moaven O
Front Immunol; 2024; 15():1287459. PubMed ID: 38361931
[TBL] [Abstract][Full Text] [Related]
10. Overcoming the Tumor Microenvironmental Barriers of Pancreatic Ductal Adenocarcinomas for Achieving Better Treatment Outcomes.
Alzhrani R; Alsaab HO; Vanamal K; Bhise K; Tatiparti K; Barari A; Sau S; Iyer AK
Adv Ther (Weinh); 2021 Jun; 4(6):. PubMed ID: 34212073
[TBL] [Abstract][Full Text] [Related]
11. An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer.
Guo J; Wang S; Gao Q
Front Immunol; 2023; 14():1258538. PubMed ID: 37771596
[TBL] [Abstract][Full Text] [Related]
12. CD13
Zhang J; Xu X; Shi M; Chen Y; Yu D; Zhao C; Gu Y; Yang B; Guo S; Ding G; Jin G; Wu CL; Zhu M
Oncoimmunology; 2017; 6(2):e1258504. PubMed ID: 28344866
[TBL] [Abstract][Full Text] [Related]
13. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.
Ene-Obong A; Clear AJ; Watt J; Wang J; Fatah R; Riches JC; Marshall JF; Chin-Aleong J; Chelala C; Gribben JG; Ramsay AG; Kocher HM
Gastroenterology; 2013 Nov; 145(5):1121-32. PubMed ID: 23891972
[TBL] [Abstract][Full Text] [Related]
14. Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma.
Olaoba OT; Yang M; Adelusi TI; Maidens T; Kimchi ET; Staveley-O'Carroll KF; Li G
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672552
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma.
Liu T; Chen Z; Chen W; Evans R; Xu J; Reeves ME; de Vera ME; Wang C
Precis Clin Med; 2023 Mar; 6(1):pbad004. PubMed ID: 37007745
[TBL] [Abstract][Full Text] [Related]
16. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
[TBL] [Abstract][Full Text] [Related]
17. The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions.
Herting CJ; Karpovsky I; Lesinski GB
Cancer Metastasis Rev; 2021 Sep; 40(3):675-689. PubMed ID: 34591240
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches.
Truong LH; Pauklin S
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638513
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single-cell analysis.
Byeon S; du Toit-Thompson T; Gillson J; Gill AJ; Samra JS; Mittal A; Sahni S
Cancer Med; 2023 Sep; 12(17):18020-18031. PubMed ID: 37537839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
